The Valley Desk

NCT05026177 · Interventional trial

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Overall registry status Terminated

Phase 3

Conditions Alzheimer Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov